Theranostics 2015; 5(9):995-1006. doi:10.7150/thno.11607 This issue Cite

Research Paper

Concomitant Retrograde Coronary Venous Infusion of Basic Fibroblast Growth Factor Enhances Engraftment and Differentiation of Bone Marrow Mesenchymal Stem Cells for Cardiac Repair after Myocardial Infarction

Xiao Wang1, Lei Zhen1, Huangtai Miao1, Qiwei Sun2, Ya Yang2, Bin Que1, Edmundo Patricio Lopes Lao1, Xingxin Wu1, Hongmei Ren1, Shutian Shi1, Wayne B. Lau3, Xinliang Ma1,3, Changsheng Ma4, Shaoping Nie1✉

1. Emergency & Critical Care Center, Beijing Anzhen Hospital, Capital Medical University, and Beijing Institute of Heart, Lung, and Blood Vessel Diseases, Beijing, China;
2. Department of Ultrasound, Beijing Anzhen Hospital, Capital Medical University, Beijing, China.
3. Department of Emergency Medicine, Thomas Jefferson University, Philadelphia, PA 19107, USA.
4. Department of Cardiology, Beijing Anzhen Hospital, Capital Medical University, Beijing, China.

Citation:
Wang X, Zhen L, Miao H, Sun Q, Yang Y, Que B, Lopes Lao EP, Wu X, Ren H, Shi S, Lau WB, Ma X, Ma C, Nie S. Concomitant Retrograde Coronary Venous Infusion of Basic Fibroblast Growth Factor Enhances Engraftment and Differentiation of Bone Marrow Mesenchymal Stem Cells for Cardiac Repair after Myocardial Infarction. Theranostics 2015; 5(9):995-1006. doi:10.7150/thno.11607. https://www.thno.org/v05p0995.htm
Other styles

File import instruction

Abstract

Graphic abstract

Aim: Basic fibroblast growth factor (bFGF) increases the migration and viability of bone marrow mesenchymal stem cells (MSCs) in vitro. Retrograde coronary venous infusion can provide both increased regional bFGF concentrations and homogeneous cell dissemination. We determined whether retrograde delivery of bFGF enhances the potency of transplanted MSCs for cardiac repair in a canine infarct model.

Methods and Results: Under hypoxic conditions, cellular migration was significantly increased in MSCs co-cultured with bFGF compared to vascular endothelial growth factor or insulin-like growth factor, and bFGF promoted MSCs differentiation into a cardiomyocyte phenotype. A canine infarct model was employed by coronary ligation. One week later, animals were subjected to retrograde infusion of combination bFGF (200ng/mL) and MSCs (1×108 cells) (n=5), MSCs (1×108 cells, n=5), bFGF (200ng/mL, n=5), or placebo (phosphate-buffered saline, n=3). Four weeks after infusion, only the bFGF+MSCs therapy exhibited significantly increased left ventricular ejection fraction (LVEF) by echocardiography (p<0.01 vs pre-infusion), and the treatment effect (delta LVEF) was greater in the bFGF+MSCs group compared to saline (7.43±1.51% versus -10.07±2.94%; p<0.001). Morphologic analysis revealed an increased infarct wall thickness in the bFGF+MSCs group compared to all others (p<0.05), accompanied by increased vascular density and reduced apoptosis. Immunofluorescence demonstrated increased cell engraftment and enhanced vascular differentiation in the bFGF+MSCs group compared to MSCs alone (p<0.05).

Conclusions: Retrograde coronary venous bFGF infusion augments engraftment and differentiation capacity of transplanted MSCs, recovering cardiac function and preventing adverse remodeling. This novel combined treatment and delivery method is a promising strategy for cardiac repair after ischemic injury.

Keywords: Cell transplantation, Growth factor, Mesenchymal stem cells, Myocardial infarction, Retrograde.


Citation styles

APA
Wang, X., Zhen, L., Miao, H., Sun, Q., Yang, Y., Que, B., Lopes Lao, E.P., Wu, X., Ren, H., Shi, S., Lau, W.B., Ma, X., Ma, C., Nie, S. (2015). Concomitant Retrograde Coronary Venous Infusion of Basic Fibroblast Growth Factor Enhances Engraftment and Differentiation of Bone Marrow Mesenchymal Stem Cells for Cardiac Repair after Myocardial Infarction. Theranostics, 5(9), 995-1006. https://doi.org/10.7150/thno.11607.

ACS
Wang, X.; Zhen, L.; Miao, H.; Sun, Q.; Yang, Y.; Que, B.; Lopes Lao, E.P.; Wu, X.; Ren, H.; Shi, S.; Lau, W.B.; Ma, X.; Ma, C.; Nie, S. Concomitant Retrograde Coronary Venous Infusion of Basic Fibroblast Growth Factor Enhances Engraftment and Differentiation of Bone Marrow Mesenchymal Stem Cells for Cardiac Repair after Myocardial Infarction. Theranostics 2015, 5 (9), 995-1006. DOI: 10.7150/thno.11607.

NLM
Wang X, Zhen L, Miao H, Sun Q, Yang Y, Que B, Lopes Lao EP, Wu X, Ren H, Shi S, Lau WB, Ma X, Ma C, Nie S. Concomitant Retrograde Coronary Venous Infusion of Basic Fibroblast Growth Factor Enhances Engraftment and Differentiation of Bone Marrow Mesenchymal Stem Cells for Cardiac Repair after Myocardial Infarction. Theranostics 2015; 5(9):995-1006. doi:10.7150/thno.11607. https://www.thno.org/v05p0995.htm

CSE
Wang X, Zhen L, Miao H, Sun Q, Yang Y, Que B, Lopes Lao EP, Wu X, Ren H, Shi S, Lau WB, Ma X, Ma C, Nie S. 2015. Concomitant Retrograde Coronary Venous Infusion of Basic Fibroblast Growth Factor Enhances Engraftment and Differentiation of Bone Marrow Mesenchymal Stem Cells for Cardiac Repair after Myocardial Infarction. Theranostics. 5(9):995-1006.

This is an open access article distributed under the terms of the Creative Commons Attribution (CC BY-NC) License. See http://ivyspring.com/terms for full terms and conditions.
Popup Image